Omalizumab (Xolair) benefitted sleep disturbance among patients with nasal polyposis over a span of 76 weeks, ... read more

As covered by Lakiea Wright, MD, in a previous interview segment with HCPLive® during the American ... read more

A collection of articles published at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 ... read more

At the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions this weekend, a ... read more

New research shows a recently revised diagnostic criteria is sufficient for emergency departments to identify and ... read more

Masks have become a key mitigation piece in the fight to stop the spread of COVID-19. However, ... read more

Sustained unresponsiveness, a pivotal, sought-after benchmark in allergic immunotherapy research, may be achievable with early initiation ... read more

Late-breaking data presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions ... read more